Early age of onset is an independent predictor for worse disease-free survival in sporadic rectal cancer patients. A comparative analysis of 980 consecutive patients
- 1 April 2022
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (4) , 857-863
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Advances and Challenges in Treatment of Locally Advanced Rectal CancerJournal of Clinical Oncology, 2015
- Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010JAMA Surgery, 2015
- Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial datasetAnnals of Oncology, 2014
- The Increasing Incidence of Young-Onset Colorectal Cancer: A Call to ActionMayo Clinic Proceedings, 2014
- Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patientsJournal of Surgical Research, 2013
- Predictive and Prognostic Roles ofBRAFMutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803Clinical Cancer Research, 2012
- Young-Onset Rectal Cancer: Presentation, Pattern of Care and Long-term Oncologic Outcomes Compared to a Matched Older-Onset CohortAnnals of Surgical Oncology, 2011
- Chemoradiation for Rectal Cancer: Rationale, Approaches, and ControversiesSurgical Oncology Clinics of North America, 2010
- Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility lociMolecular Cancer, 2010
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 TrialJournal of Clinical Oncology, 2010